Literature DB >> 18303662

[Acute low back pain--assessment and management].

O P Gautschi1, G Hildebrandt, D Cadosch.   

Abstract

Acute low back pain is a very common symptom. Up to 90% of all adults suffer at least once in their life from a low back pain episode, in the majority of cases a nonspecific lumbago. They are, with or without sciatica, usually self-limited and have no serious underlying pathology and subside in 80-90% of the concerned patients within six weeks. Beside a sufficient pain medication and physiotherapy, reassurance about the overall benign character and the favourable prognosis of the medical condition should be in the centre of the therapeutic efforts. A more thorough assessment is required for selected patients with warning signs, so called "red flags" findings, because they are associated with an increased risk of cauda equina syndrome, cancer, infection, or fracture. These patients also require a closer follow-up and, in some cases, an urgent surgical intervention. Among patients with acute nonspecific mechanical low back pain, imaging diagnostic can be delayed for at least four to six weeks, which usually allows the medical condition to improve. From a therapeutic viewpoint, there is enough evidence for the effectiveness of paracetamol, nonsteroidal anti-inflammatory drugs, skeletal muscle relaxants, heat therapy, physiotherapy, and the advice to stay "active". A complete relief and protection represent an out-dated concept, because the deconditioning is stimulated and the return to the workplace is needlessly delayed. Spinal manipulative therapy may provide short-term benefits in certain patients. In a multimodal therapeutic concept, the patient education should focus on the natural history of an acute back pain episode, the overall good prognosis, and recommendations for an effective treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18303662     DOI: 10.1024/1661-8157.97.2.58

Source DB:  PubMed          Journal:  Praxis (Bern 1994)        ISSN: 1661-8157


  7 in total

1.  The safety and efficacy of minimally invasive discectomy: a meta-analysis of prospective randomised controlled trials.

Authors:  Xian Chang; Bin Chen; Hai-yin Li; Xiao-bo Han; Yue Zhou; Chang-qing Li
Journal:  Int Orthop       Date:  2014-04-11       Impact factor: 3.075

2.  The efficacy of thermotherapy and cryotherapy on pain relief in patients with acute low back pain, a clinical trial study.

Authors:  Morteza Dehghan; Farinaz Farahbod
Journal:  J Clin Diagn Res       Date:  2014-09-20

3.  What were the advantages of microendoscopic discectomy for lumbar disc herniation comparing with open discectomy: a meta-analysis?

Authors:  Xiaoping Mu; Jianxun Wei; Peifeng Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  To compare the efficacy and safety of fixed dose combination of thiocolchicoside and aceclofenac versus chlorzoxazone, aceclofenac and paracetamol in patients with acute lower backache associated with muscle spasm.

Authors:  Sanjeev Kumar; Seema Rani; Ramchander Siwach; Prem Verma
Journal:  Int J Appl Basic Med Res       Date:  2014-07

5.  Lumbar Scoliosis Combined Lumbar Spinal Stenosis and Herniation Diagnosed Patient Was Treated with "U" Route Transforaminal Percutaneous Endoscopic Lumbar Discectomy.

Authors:  Binbin Wu; Shaobo Zhang; Qingquan Lian; Haibo Yan; Xianfa Lin; Gonghao Zhan
Journal:  Case Rep Orthop       Date:  2017-01-19

Review 6.  A Comparison of Percutaneous Endoscopic Lumbar Discectomy and Open Lumbar Microdiscectomy for Lumbar Disc Herniation in the Korean: A Meta-Analysis.

Authors:  Manyoung Kim; Sol Lee; Hyeun-Sung Kim; Sangyoon Park; Sang-Yeup Shim; Dong-Ju Lim
Journal:  Biomed Res Int       Date:  2018-08-07       Impact factor: 3.411

7.  Better Functional Outcome and Pain Relief in the Far-Lateral-Outside-in Percutaneous Endoscopic Transforaminal Discectomy.

Authors:  Sheng-Fen Wang; Shih-Feng Hung; Tsung-Ting Tsai; Yun-Da Li; Ping-Yeh Chiu; Ming-Kai Hsieh; Fu-Cheng Kao
Journal:  J Pain Res       Date:  2021-12-30       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.